Research on cd20, a component of b-cell biology, is ongoing, with its regulation and function still not fully understood. The study of cd20 and related topics, such as b-cell-derived exosomes and immune tolerance, may have implications for targeted therapy and anti-tumor treatment. Various potential therapeutic strategies are being explored, including targeting specific proteins and enhancing natural killer cell cytotoxicity.